Alpha Packaging Expands HDPE Manufacturing Platform on the East Coast - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Alpha Packaging Expands HDPE Manufacturing Platform on the East Coast



Alpha Packaging has qualified six new injection blow molded high-density polyethylene (HDPE) packers as part of its new HDPE Pharma Line. When completed later this fall, Alpha’s Pharma Line will consist of more than a dozen injection blow molded and extrusion blow molded bottles that replicate the HDPE round bottles most prevalent in the pharmaceutical industry. The new line will also contribute to Alpha’s core customer base of nutritional supplement manufacturers and fillers, many of which are located near the company’s Bethlehem, Pa., manufacturing site.

Alpha is investing in new IBM and EBM machines and new molds for more than a dozen sizes of bottles, ranging from 50 cc to 950 cc. Sizes up to 300 cc will be manufactured on new equipment using the injection blow molding process. Larger sizes will be extrusion blow molded on new equipment with new blow molds.

Source: Alpha Packaging

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy

Click here